Janus kinase inhibitors and uses thereof

作者: Nathanael S. Gray , Li Tan

DOI:

关键词:

摘要: The present invention provides kinase inhibitors, such as compounds of Formula (I) and (II). may covalently or non-covalently bind a (e.g., Janus 3 (JAK3)). Also provided are pharmaceutical compositions, kits, methods, uses that involve the for reducing activity and/or treating preventing condition associated with aberrant proliferative disease, inflammatory disorder, autoimmune painful condition, viral infection). (II)

参考文章(288)
Vicki Brower, Tumor angiogenesis : new drugs on the block Nature Biotechnology. ,vol. 17, pp. 963- 968 ,(1999) , 10.1038/13654
James P. Karwowski, Jill E. Hochlowski, Marianna Jackson, Sunil K. Kadam, James B. McAlpine, Dorrigocin antitumor agents ,(1995)
Steven F. Peterson, Ampule filling device ,(1996)
Andrea König, Gary K. Schwartz, Ramzi M. Mohammad, Ayad Al-Katib, Janice L. Gabrilove, The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines Blood. ,vol. 90, pp. 4307- 4312 ,(1997) , 10.1182/BLOOD.V90.11.4307
Mélissanne de Wispelaere, Nathanael S. Gray, Priscilla L. Yang, Qingsong Liu, Host targeted inhibitors of dengue virus and other viruses ,(2013)